Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 6

Results: 24

Loss of ATRX suppresses anti-tumor immunity.

Published in:

2022

By:

Diaz, Aaron A

Publication type:

Editorial

Radiomics—A new age of presurgical assessment to improve outcomes in pediatric neuro-oncology.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 995, doi. 10.1093/neuonc/noac046

By:

Valvi, Santosh;
Hansford, Jordan R

Publication type:

Article

Forthcoming Meetings.

Published in:: Neuro-Oncology, 2022, v. 24, n. 6, p. 1034, doi. 10.1093/neuonc/noac129
Publication type:: Article

Bioethical implications of current state practices of molecular diagnostics in neuropathology.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 853, doi. 10.1093/neuonc/noac058

By:

Wang, Wesley;
Howard, Dana;
Giglio, Pierre;
Thomas, Diana;
Otero, José Javier

Publication type:

Article

TRK inhibition for pediatric and adult central nervous system tumors: Early promise and future questions.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 1008, doi. 10.1093/neuonc/noac048

By:

Mangum, Ross;
Parsons, Donald Williams

Publication type:

Article

Chemotherapy plus focal radiation therapy for localized intracranial germinoma: How little is enough?

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 984, doi. 10.1093/neuonc/noac047

By:

Sait, Sameer Farouk;
Karajannis, Matthias A

Publication type:

Article

Pediatric ependymoma: New perspectives on older trials.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 949, doi. 10.1093/neuonc/noac060

By:

Crotty, Erin;
Gust, Juliane

Publication type:

Article

Standardizing reporting of brain and central nervous system tumors in the United Kingdom.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 1032, doi. 10.1093/neuonc/noac027

By:

Poon, Michael T C;
Brennan, Paul M;
Jin, Kai;
Sudlow, Cathie L M;
Figueroa, Jonine D

Publication type:

Article

Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib.

Published in:

2022

By:

Papusha, Ludmila;
Zaytseva, Margarita;
Panferova, Agnesa;
Druy, Alexander;
Valiakhmetova, Andge;
Artemov, Anton;
Salnikova, Ekaterina;
Kislyakov, Alexey;
Imyanitov, Evgeny;
Karachunsky, Alexander;
Maschan, Alexey;
Hwang, Eugene I;
Novichkova, Galina;
Packer, Roger J

Publication type:

Case Study

CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 886, doi. 10.1093/neuonc/noac020

By:

Yoda, Hiroyuki;
Weiss, William A

Publication type:

Article

SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 936, doi. 10.1093/neuonc/noac012

By:

Ritzmann, Timothy A;
Chapman, Rebecca J;
Kilday, John-Paul;
Thorp, Nicola;
Modena, Piergiorgio;
Dineen, Robert A;
Macarthur, Donald;
Mallucci, Conor;
Jaspan, Timothy;
Pajtler, Kristian W;
Giagnacovo, Marzia;
Jacques, Thomas S;
Paine, Simon M L;
Ellison, David W;
Bouffet, Eric;
Grundy, Richard G

Publication type:

Article

Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 855, doi. 10.1093/neuonc/noac004

By:

Soffietti, Riccardo;
Bettegowda, Chetan;
Mellinghoff, Ingo K;
Warren, Katherine E;
Ahluwalia, Manmeet S;
Groot, John F De;
Galanis, Evanthia;
Gilbert, Mark R;
Jaeckle, Kurt A;
Rhun, Emilie Le;
Rudà, Roberta;
Seoane, Joan;
Thon, Niklas;
Umemura, Yoshie;
Weller, Michael;
Bent, Martin J van den;
Vogelbaum, Michael A;
Chang, Susan M;
Wen, Patrick Y

Publication type:

Article

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 997, doi. 10.1093/neuonc/noab274

By:

Doz, François;
Tilburg, Cornelis M van;
Geoerger, Birgit;
Højgaard, Martin;
Øra, Ingrid;
Boni, Valentina;
Capra, Michael;
Chisholm, Julia;
Chung, Hyun Cheol;
DuBois, Steven G;
Gallego-Melcon, Soledad;
Gerber, Nicolas U;
Goto, Hiroaki;
Grilley-Olson, Juneko E;
Hansford, Jordan R;
Hong, David S;
Italiano, Antoine;
Kang, Hyoung Jin;
Nysom, Karsten;
Thorwarth, Anne

Publication type:

Article

Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 925, doi. 10.1093/neuonc/noab291

By:

Cai, Feng;
Chen, Shasha;
Yu, Xuebin;
Zhang, Jing;
Liang, Weiwei;
Zhang, Yan;
Chen, Yike;
Chen, Sheng;
Hong, Yuan;
Yan, Wei;
Wang, Wei;
Zhang, Jianmin;
Wu, Qun

Publication type:

Article

Neuronal exposure induces neurotransmitter signaling and synaptic mediators in tumors early in brain metastasis.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 914, doi. 10.1093/neuonc/noab290

By:

Deshpande, Krutika;
Martirosian, Vahan;
Nakamura, Brooke Naomi;
Iyer, Mukund;
Julian, Alex;
Eisenbarth, Rachel;
Shao, Ling;
Attenello, Frank;
Neman, Josh

Publication type:

Article

Origins of biallelic inactivation of NF2 in neurofibromatosis type 2.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 903, doi. 10.1093/neuonc/noab287

By:

Xue, Lu;
He, Weiwei;
Zhang, Yi;
Wang, Zhigang;
Chen, Hongsai;
Chen, Zhe;
Zhu, Weidong;
Liu, Dongmei;
Jia, Huan;
Jiang, Yi;
Wang, Zhaoyan;
Wu, Hao

Publication type:

Article

Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 1020, doi. 10.1093/neuonc/noab276

By:

Hagiwara, Akifumi;
Oughourlian, Talia C;
Cho, Nicholas S;
Schlossman, Jacob;
Wang, Chencai;
Yao, Jingwen;
Raymond, Catalina;
Everson, Richard;
Patel, Kunal;
Mareninov, Sergey;
Rodriguez, Fausto J;
Salamon, Noriko;
Pope, Whitney B;
Nghiemphu, Phioanh L;
Liau, Linda M;
Prins, Robert M;
Cloughesy, Timothy F;
Ellingson, Benjamin M

Publication type:

Article

ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 888, doi. 10.1093/neuonc/noab292

By:

Hu, Chengchen;
Wang, Kimberly;
Damon, Ceylan;
Fu, Yi;
Ma, Tengjiao;
Kratz, Lisa;
Lal, Bachchu;
Ying, Mingyao;
Xia, Shuli;
Cahill, Daniel P;
Jackson, Christopher M;
Lim, Michael;
Laterra, John;
Li, Yunqing

Publication type:

Article

Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 986, doi. 10.1093/neuonc/noab272

By:

Zhang, Michael;
Wang, Edward;
Yecies, Derek;
Tam, Lydia T;
Han, Michelle;
Toescu, Sebastian;
Wright, Jason N;
Altinmakas, Emre;
Chen, Eric;
Radmanesh, Alireza;
Nemelka, Jordan;
Oztekin, Ozgur;
Wagner, Matthias W;
Lober, Robert M;
Ertl-Wagner, Birgit;
Ho, Chang Y;
Mankad, Kshitij;
Vitanza, Nicholas A;
Cheshier, Samuel H;
Jacques, Tom S

Publication type:

Article

Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 951, doi. 10.1093/neuonc/noab271

By:

Chiocca, E Antonio;
Gelb, Arnold B;
Chen, Clark C;
Rao, Ganesh;
Reardon, David A;
Wen, Patrick Y;
Bi, Wenya Linda;
Peruzzi, Pierpaolo;
Amidei, Christina;
Triggs, Dan;
Seften, Leah;
Park, Grace;
Grant, James;
Truman, Kyla;
Buck, Jill Y;
Hadar, Nira;
Demars, Nathan;
Miao, John;
Estupinan, Taylor;
Loewy, John

Publication type:

Article

Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 974, doi. 10.1093/neuonc/noab270

By:

Bartels, Ute;
Onar-Thomas, Arzu;
Patel, Sunita K;
Shaw, Dennis;
Fangusaro, Jason;
Dhall, Girish;
Souweidane, Mark;
Bhatia, Aashim;
Embry, Leanne;
Trask, Christine L;
Murphy, Erin S;
MacDonald, Shannon;
Wu, Shengjie;
Boyett, James M;
Leary, Sarah;
Fouladi, Maryam;
Gajjar, Amar;
Khatua, Soumen

Publication type:

Article

Decade-long disease, secondary malignancy, and brainstem injury outcomes in pediatric and young adult medulloblastoma patients treated with proton radiotherapy.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 1010, doi. 10.1093/neuonc/noab257

By:

Baliga, Sujith;
Gallotto, Sara;
Bajaj, Benjamin;
Lewy, Jacqueline;
Weyman, Elizabeth;
Lawell, Miranda P;
Yeap, Beow Y;
Ebb, David E;
Huang, Mary;
Caruso, Paul;
Perry, Alisa;
Jones, Robin M;
MacDonald, Shannon M;
Tarbell, Nancy J;
Yock, Torunn I

Publication type:

Article

Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 872, doi. 10.1093/neuonc/noab241

By:

Weng, Zhihui;
Lin, Jiacheng;
He, Jiaozi;
Gao, Lin;
Lin, Sien;
Tsang, Lai Ling;
Zhang, Hang;
He, Xiaoyan;
Wang, Guang;
Yang, Xuesong;
Zhou, Hu;
Zhao, Hui;
Li, Gang;
Zou, Lin;
Jiang, Xiaohua

Publication type:

Article

Characterization and prognosis of temozolomide-induced aplastic anemia in patients with central nervous system malignancies.

Published in:

Neuro-Oncology, 2022, v. 24, n. 6, p. 964, doi. 10.1093/neuonc/noab240

By:

Park, Albert K;
Waheed, Anem;
Forst, Deborah A;
Al-Samkari, Hanny

Publication type:

Article